Towards Neoatherosclerosis: A Porcine Model for Enhanced Device Testing
Journal of Cardiovascular Translational Research · 2026-12 · 19 (1)
DOI: 10.1007/s12265-026-10778-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Translational Research, online erschienen am 26.05.2026. Verfasst von Jing Xie und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Charité …. Hauptthemen laut MEDLINE: Coronary Vessels, Neointima, Stents, Peripheral Arterial Disease. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Charité - Universitätsmedizin Berlin.
Abstract (Originalsprache)
The porcine in-stent stenosis model has been essential for developing drug-coated devices but does not replicate the hyperlipidemic, pro-atherogenic conditions driving neoatherosclerosis. We aimed to establish a practical porcine model for testing endovascular therapies targeting neoatherosclerosis. Juvenile pigs were fed a high-fat, nicotine-supplemented diet (HFDN). After two weeks, bare-metal stents were implanted in coronary and peripheral arteries; controls received a standard diet. Four weeks later, stented, and non-stented artery segments were analyzed. HFDN feeding induced elevated serum LDL and cotinine. At follow-up, in-stent late lumen loss was significantly greater in peripheral arteries (A. iliaca: 2.3 ± 0.6 vs. 1.1 ± 0.5 mm; A. femoralis: 3.4 ± 1.2 vs. 2.0 ± 0.4 mm), but not coronary arteries. HFDN-fed pigs showed distinct signs of early neoatherosclerosis, including peri-strut foam cell accumulations and atheroma formation. Elemental imaging and chemical analysis confirmed increased calcium phosphate deposition in arteries of HFDN-fed pigs. This straightforward protocol enables testing of devices aimed at preventing or treating neoatherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Charité Campus Mitte, Charitéplatz 1, 10117, Berlin, Germany.
- InnoRa GmbH, Robert-Koch-Platz 4, 10115, Berlin, Germany.
- Clinical and Experimental Interventional Cardiology, University of Saarland, 66421, Homburg Saar, Germany.
- Bundesanstalt für Materialforschung und -prüfung (BAM), Richard-Willstätter-Straße 11, 12489, Berlin, Germany.
- Department of Radiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Charité Campus Mitte, Charitéplatz 1, 10117, Berlin, Germany. tobias.haase@cha…
- InnoRa GmbH, Robert-Koch-Platz 4, 10115, Berlin, Germany. tobias.haase@charite.de.
ORCID-Profile: Tobias Haase
Förderung
- Charité - Universitätsmedizin Berlin
Zitieren
APA
Xie, J., Gemeinhardt, O., Bettink, S., Hauptmann, R., Schannor, M., Loechel, M., Speck, U., & Haase, T. (2026). Towards Neoatherosclerosis: A Porcine Model for Enhanced Device Testing. Journal of Cardiovascular Translational Research, 19(1). https://doi.org/10.1007/s12265-026-10778-4
Vancouver
Xie J, Gemeinhardt O, Bettink S, Hauptmann R, Schannor M, Loechel M, et al. Towards Neoatherosclerosis: A Porcine Model for Enhanced Device Testing. Journal of Cardiovascular Translational Research. 2026;19(1). doi:10.1007/s12265-026-10778-4
BibTeX
@article{Xie2026,
author = {Xie, Jing and Gemeinhardt, Ole and Bettink, Stephanie and Hauptmann, Ralf and Schannor, Mathias and Loechel, Melanie and Speck, Ulrich and Haase, Tobias},
title = {Towards Neoatherosclerosis: A Porcine Model for Enhanced Device Testing},
journal = {Journal of Cardiovascular Translational Research},
year = {2026},
volume = {19},
number = {1},
doi = {10.1007/s12265-026-10778-4}
}
EUVIMED